Gain Therapeutics Investor Call to Discuss Results from Phase 1 Study of GT-02287 In Development for Parkinson’s Disease
| DATE: | September 30, 2024 |
|---|---|
| TIME: | 8:30 AM EDT |
| LOCATION: | Virtual |
About The Event
Positive Results and Design of Planned Phase 1b Study Recently Presented at the International Congress of Parkinson’s Disease and Movement Disorders